Alexander Steinkasserer, studied biology at the University of Innsbruck. From 1986 until 1989 he worked as a Postdoctoral Fellow at the Institute for Immunology at the Ludwig-Maximilians-Universität München (LMU) and subsequently as a Research Fellow at the University of Oxford (1989-93). From 1993 until 1996 he was laboratory head at the Novartis Research Institute in Vienna and from 1996 until 1997 head of division at the Baxter AG Vienna. From 1997 until 1998 he served as head of division at the Immunological Day Clinic Vienna. Since 1998 he is appointed professor at the Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and head of the department of “Immune Modulation”, at the University Hospital Erlangen. His research interests are focused on the human immune system, with the long term aim to develop new therapeutic strategies for patients suffering from cancer, infections or autoimmune disorders. He published over 150 scientific articles in peer reviewed international journals. In addition, several international patents have been granted to Prof. Steinkasserer, which represents the intellectual property to successfully translate basic research into applicable and economically sustainable therapy approaches. Furthermore, he very successfully acquired third party money, amongst others, from the “German Science Foundation”.
